In this study, E33 expression was significantly correlated with TNM stage, lymph node metastasis, and family history, but not correlated with patient's age and tumor grade, as well as ER, PR, and Her2 status. This evidence concerns the gene ERBB2 and metastatic malignant neoplasm in the lymph nodes.